| Citation: |
SHI Jin, LI Daojuan, LIANG Di, JIN Jing, WEN Denggui, HE Yutong. Liver Cancer Incidence and Mortality Rates During Last 40 Years in Hebei Province[J]. Cancer Research on Prevention and Treatment, 2016, 43(11): 990-995. DOI: 10.3971/j.issn.1000-8578.2016.11.014
|
To estimate the liver cancer burden and analyze the trend of the mortality rate during last 40 years in Hebei Province.
Cancer registry data from nine cancer registries in Hebei Province were qualified and checked according to the regulations from the National Cancer Registry Center. The pooled data were stratified by gender and age. Incidence and mortality rates were calculated and expressed in 1/100 000. Liver cancer mortality data during the three periods were extracted and calculated from the national death surveys. Mortality and incidence trends in Ci County from 1988 to 2012 were analyzed by Joinpoint Regression Models.
The newly liver cancer cases and deaths from 2010 to 2012 in Hebei Province were 2 552 and 2 447,respectively. The crude incidence rate (CIR) of liver cancer was 18.26/100 000 (24.89/100 000 in male and 11.40/100 000 in female). The age-standardized incidence rate by world standard population (ASIRW) was 15.32/100 000,ranking the fifth of all cancers. The crude mortality rate(CMR) of liver cancer was 17.51/100 000(23.71/100 000 in male and 11.09/100 000 in female). The age-standardized mortality rate by world standard population(ASMRW) was 15.05/100 000,which was the fourth leading case of cancer death. The mortality rates displayed an increasing trend in Hebei Province during last 40 years as a whole,with an increased rate of 15.95%. In Ci County,the trends of incidence and mortality for both genders were similar.
The incidence and mortality rates of liver cancer in Hebei Province are much higher than the average level in the world. There is still a heavy health burden for liver cancer in Hebei Province. Thus,it is necessary to go on with taking measures to prevent and control liver cancer in the future.
| [1] |
Ferlay J, Soerjomataram I, Dikdhit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in CLOBOCAN 2012[J]. Int J Cancer, 2015, 36(1): E359-86.
|
| [1] |
Ferlay J,Soerjomataram I,Dikdhit R,et al. Cancer incidence and mortality worldwide: Sources,methods and major patterns in CLOBOCAN 2012[J]. Int J Cancer,2015,36(1): E359-86. http://cn.bing.com/academic/profile?id=1757407923&encoded=0&v=paper_preview&mkt=zh-cn
|
| [2] |
Global Burden of Disease Cancer C,Fitzmaurice C,Dicker D,et al. The Global Burden of Cancer 2013[J]. JAMA Oncol,2015,1(4): 505-27. doi: 10.1001/jamaoncol.2015.0735
|
| [2] |
Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, et al. The Global Burden of Cancer 2013[J]. JAMA Oncol, 2015, 1(4): 505-27.
|
| [3] |
Chen W,Zheng RS. Zeng H. et al. Annual report on status of cancer in China,2011[J]. Chin J Cancer Res,2015,27(1): 2-12. http://cn.bing.com/academic/profile?id=2129000805&encoded=0&v=paper_preview&mkt=zh-cn
|
| [3] |
Chen W, Zheng RS. Zeng H. et al. Annual report on status of cancer in China, 2011[J]. Chin J Cancer Res, 2015, 27(1): 2-12.
|
| [4] |
中国卫生部国家肿瘤防治办公室. 中国肿瘤死因调查报告[M]. 北京: 人民卫生出版社, 1980. 335-8. [National Office of Cancer Prevention and Treatment, Ministry of Health. Malignant tumor mortality survey report in China[M]. Beijing: People’s Medical Publishing House, 1980. 335-8]
|
| [4] |
中国卫生部国家肿瘤防治办公室. 中国肿瘤死因调查报告[M]. 北京: 人民卫生出版社,1980: 335-8.
National Office of Cancer Prevention and Treatment,Ministry of Health. Malignant tumor mortality survey report in China[M]. Beijing: People’s Medical Publishing House,1980: 335-8
|
| [5] |
全国肿瘤防治研究办公室. 中国1990-1992年癌症死因调查[M]. 北京: 人民卫生出版社,1993: 534-629.
National Office of Cancer Prevention and Treatment. Survey of cancer mortality in China 1990-1992[M]. Beijing: People‘s Medical Publishing House,1993: 534-629.
|
| [5] |
全国肿瘤防治研究办公室. 中国1990–1992年癌症死因调查 [M]. 北京: 人民卫生出版社, 1993. 534-629. [National Office of Cancer Prevention and Treatment. Survey of cancer mortality in China 1990–1992[M]. Beijing: People‘s Medical Publishing House, 1993. 534-629.]
|
| [6] |
全国肿瘤防治研究办公室. 中国肿瘤死亡报告 全国第三次死因回顾抽样调查[M]. 北京: 人民卫生出版社,2010: 256-371.
National Office of Cancer Prevention and Treatment. Malignant tumor mortality report in China,the third review sampling survey for death causes[M]. Beijing: People’s Medical Publishing House,2010: 256-371.
|
| [6] |
全国肿瘤防治研究办公室. 中国肿瘤死亡报告 全国第三次死 因回顾抽样调查[M]. 北京: 人民卫生出版社, 2010. 256-371. [National Office of Cancer Prevention and Treatment. Malignant tumor mortality report in China, the third review sampling survey for death causes[M]. Beijing: People’s Medical Publishing House, 2010. 256-371.]
|
| [7] |
Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents Vol.Ⅷ[M]. Lyon: IARC Scientific Publications, 2002, 5-217.
|
| [7] |
Parkin DM,Whelan SL,Ferlay J,et al. Cancer Incidence in Five Continents Vol.Ⅷ[M]. Lyon: IARC Scientific Publications,2002: 5-217.
|
| [8] |
Forman D,Bray F,Brewster DH,et al. Cancer Incidence in Five Continents Vol.Ⅹ[M]. Lyon: IARC Scientific Publications,2014:14-509.
|
| [8] |
Forman D, Bray F, Brewster DH, et al. Cancer Incidence in Five Continents Vol.Ⅹ[M]. Lyon: IARC Scientific Publications, 2014, 14-509.
|
| [9] |
Bray F, Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. PartⅠ: comparability, validity and timelines[J]. Eur J Cancer, 2009, 45(5): 747-55.
|
| [9] |
Bray F,Parkin DM. Evaluation of data quality in the cancer registry: principles and methods. PartⅠ: comparability,validity and timelines[J]. Eur J Cancer,2009,45(5): 747-55. doi: 10.1016/j.ejca.2008.11.032
|
| [10] |
Parkin DM, Chen VW, Ferlay J, et al. Comparability and Quality Control in Cancer Registratio[M]. Lyon: IARC Technical Report, 1996. 1-116.
|
| [10] |
Parkin DM,Chen VW,Ferlay J,et al. Comparability and Quality Control in Cancer Registratio[M]. Lyon: IARC Technical Report,1996: 1-116.
|
| [11] |
Felay J,Burkhard C,Whelan S,et al. Check and Conversion Program for Cancer Registries[M]. Lyon: IARC Technical Report,2005: 1-46.
|
| [11] |
Felay J, Burkhard C, Whelan S, et al. Check and Conversion Program for Cancer Registries[M]. Lyon: IARC Technical Report, 2005. 1-46.
|
| [12] |
McGlynn KA,Petrick JL,London WT. Global Epidemiology of Hepatocellular Carcinoma: an emphasis on demographic and regional variability[J]. Clin Liver Dis,2015,19(2): 223-38. doi: 10.1016/j.cld.2015.01.001
|
| [12] |
McGlynn KA, Petrick JL, London WT. Global Epidemiology of Hepatocellular Carcinoma: an emphasis on demographic and regional variability[J]. Clin Liver Dis, 2015, 19(2): 223-38.
|
| [13] |
Bosetti C,Turati F,La Vecchia C. Hepatocellular carcinoma epidemiology[J]. Best Pract Res Clin Gastroenterol,2014,28(5): 753-70. doi: 10.1016/j.bpg.2014.08.007
|
| [13] |
Bosetti C, Turati F, La Vecchia C. Hepatocellular carcinoma epidemiology[J]. Best Pract Res Clin Gastroenterol, 2014, 28(5): 753-70.
|
| [14] |
陈建国,张思维,陈万青. 中国2004-2005年全国死因回顾抽样调查肝癌死亡率分析[J]. 中华预防医学杂志,2010,44(5): 383-9.
Chen JG,Zhang SW,Chen WQ. Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China,2004-2005[J]. Zhonghua Yu Fang Yi Xue Za Zhi,2010,44(5): 383-9.
|
| [14] |
陈建国, 张思维, 陈万青. 中国2004-2005年全国死因回顾抽 样调查肝癌死亡率分析[J]. 中华预防医学杂志, 2010, 44(5): 383-9. [Chen JG, Zhang SW, Chen WQ. Analysis of liver cancer mortality in the national retrospective sampling survey of death causes in China, 2004-2005[J]. Zhonghua Yu Fang Yi Xue Za Zhi, 2010, 44(5): 383-9.]
|
| [15] |
Zuo TT, Zheng RS, Zhang SW, et al. Incidence and mortality of liver cancer in China in 2011[J]. Chin J Cancer, 2015, 34(11): 508-13.
|
| [15] |
Zuo TT,Zheng RS,Zhang SW,et al. Incidence and mortality of liver cancer in China in 2011[J]. Chin J Cancer,2015,34(11): 508-13. http://cn.bing.com/academic/profile?id=2107211154&encoded=0&v=paper_preview&mkt=zh-cn
|
| [16] |
McGlynn KA,Tsao L,Hsing AW,et al. International trends and patterns of primary liver cancer[J]. Int J Cancer,2001,94(2): 290-6. doi: 10.1002/(ISSN)1097-0215
|
| [16] |
McGlynn KA, Tsao L, Hsing AW, et al. International trends and patterns of primary liver cancer[J]. Int J Cancer, 2001, 94(2): 290-6.
|
| [17] |
Jemal A,Center MM,DeSantis C,et al. Global patterns of cancer incidence and mortality rates and trends[J]. Cancer Epidemiol Biomarkers Prev,2010,19(8): 1893-907. doi: 10.1158/1055-9965.EPI-10-0437
|
| [17] |
Jemal A, Center MM, DeSantis C, et al. Global patterns of cancer incidence and mortality rates and trends[J]. Cancer Epidemiol Biomarkers Prev, 2010, 19(8): 1893-907.
|
| [18] |
Zhu Q,Li N,Zeng X,et al. Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival[J]. Oncotarget,2015,6(6): 4440-50. doi: 10.18632/oncotarget
|
| [18] |
Zhu Q, Li N, Zeng X, et al. Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival[J]. Oncotarget, 2015, 6(6): 4440-50.
|
| [19] |
Chien YC, Jan CF, Chiang CJ, et al. Incomplete hepatitis B immunization, maternal carrier status, and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees[J]. Hepatology, 2014, 60(1): 125-32.
|
| [19] |
Chien YC,Jan CF,Chiang CJ,et al. Incomplete hepatitis B immunization,maternal carrier status,and increased risk of liver diseases: a 20-year cohort study of 3.8 million vaccinees[J]. Hepatology,2014,60(1): 125-32. doi: 10.1002/hep.v60.1
|
| [20] |
郑荣寿, 左婷婷, 曾红梅, 等. 中国肝癌死亡状况与生存分析[J]. 中华肿瘤杂志, 2015, 37(9): 697-702. [Zheng RS, Zuo TT, Zeng HM, et al. [Mortality and survival analysis of liver cancer in China[J]. Zhonghua Zhong Liu Za Zhi, 2015, 37(9): 697-702.]
|
| [20] |
郑荣寿,左婷婷,曾红梅,等. 中国肝癌死亡状况与生存分析[J]. 中华肿瘤杂志,2015,37(9): 697-702.
Zheng RS,Zuo TT,Zeng HM,et al. [Mortality and survival analysis of liver cancer in China[J]. Zhonghua Zhong Liu Za Zhi,2015,37(9): 697-702.
|
| [21] |
Chen WQ,Zheng RS,Zeng HM,et al. The updated incidences and mortalities of major cancers in China,2011[J]. Chinese J Cancer,2015,34(11): 502-7. http://cn.bing.com/academic/profile?id=2102927853&encoded=0&v=paper_preview&mkt=zh-cn
|
| [21] |
Chen WQ, Zheng RS, Zeng HM, et al. The updated incidences and mortalities of major cancers in China, 2011[J]. Chinese J Cancer, 2015, 34(11): 502-7.
|
| [22] |
Wang N, Zheng Y, Yu X, et al. Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer[J]. Am J Epidemiol, 2009, 169(8): 990-5.
|
| [22] |
Wang N,Zheng Y,Yu X,et al. Sex-modified effect of hepatitis B virus infection on mortality from primary liver cancer[J]. Am J Epidemiol,2009,169(8): 990-5. doi: 10.1093/aje/kwn418
|
| [23] |
Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to Hepatitis B vaccination[J]. Vaccine, 2009, 27(47): 6550-7.
|
| [23] |
Liang X,Bi S,Yang W,et al. Epidemiological serosurvey of hepatitis B in China-declining HBV prevalence due to Hepatitis B vaccination[J]. Vaccine,2009,27(47): 6550-7. doi: 10.1016/j.vaccine.2009.08.048
|
| [24] |
陈建国. 中国肝癌发病趋势和一级预防[J]. 临床肝胆病杂志, 2012, 28(4): 256-60. [Chen JG. Trends in the incidence of liver cancer and its primary prevention in China[J]. Lin Chuang Gan Dan Bing Za Zhi, 2012, 28(4): 256-60.]
|
| [24] |
陈建国. 中国肝癌发病趋势和一级预防[J]. 临床肝胆病杂志,2012,28(4): 256-60. http://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201204011.htm
Chen JG. Trends in the incidence of liver cancer and its primary prevention in China[J]. Lin Chuang Gan Dan Bing Za Zhi,2012,28(4): 256-60. http://www.cnki.com.cn/Article/CJFDTOTAL-LCGD201204011.htm
|
| [25] |
Wang FS,Fan JG,Zhang Z,et al. The global burden of liver disease: the major impact of China[J]. Hepatology,2014,60(6): 2099-108. doi: 10.1002/hep.v60.6
|
| [25] |
Wang FS, Fan JG, Zhang Z, et al. The global burden of liver disease: the major impact of China[J]. Hepatology, 2014, 60(6): 2099-108.
|
| [26] |
Yang G,Wang Y,Zeng Y,et al. Rapid health transition in China,1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet,2013,381(9882): 1987-2015. doi: 10.1016/S0140-6736(13)61097-1
|
| [26] |
Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990–2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9882): 1987-2015.
|
| [27] |
Fan JH, Wang JB, Jiang Y, et al. Attributable causes of liver cancer mortality and incidence in China[J]. Asian Pac J Cancer Prev, 2013, 14(12): 7251-6.
|
| [27] |
Fan JH,Wang JB,Jiang Y,et al. Attributable causes of liver cancer mortality and incidence in China[J]. Asian Pac J Cancer Prev,2013,14(12): 7251-6. doi: 10.7314/APJCP.2013.14.12.7251
|
| [28] |
Calle EE,Rodriguez C,Walker-Thurmond K,et al. Overweight,obesity,and mortality from cancer in a prospectively studied cohort of U.S. adults[J]. N Enql J Med,2003,348(17): 1625-38. doi: 10.1056/NEJMoa021423
|
| [28] |
Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults[J]. N Enql J Med, 2003, 348(17): 1625-38.
|
| [29] |
Setiawan VW, Lim U, Lipworth L, et al. Sex and ethnic differences in the association of obesity with risk of hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol, 2016, 14(2): 309-16.
|
| [29] |
Setiawan VW,Lim U,Lipworth L,et al. Sex and ethnic differences in the association of obesity with risk of hepatocellular carcinoma[J]. Clin Gastroenterol Hepatol,2016,14(2): 309-16. doi: 10.1016/j.cgh.2015.09.015
|
| [30] |
Schlesinger S, Aleksandrova K, Pischon T, et al. Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort[J]. Int J Cancer, 2013, 132(3): 645-57.
|
| [30] |
Schlesinger S,Aleksandrova K,Pischon T,et al. Abdominal obesity,weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort[J]. Int J Cancer,2013,132(3): 645-57. doi: 10.1002/ijc.v132.3
|
| [31] |
Chen CL,Yang HI,Yang WS,et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan[J]. Gastroenterology,2008,135(1): 111-21. doi: 10.1053/j.gastro.2008.03.073
|
| [31] |
Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan[J]. Gastroenterology, 2008, 135(1): 111-21.
|
| [32] |
Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends[J]. Gastroenterology, 2004, 127(5 Suppl 1): S5-16.
|
| [32] |
Bosch FX,Ribes J,Diaz M,et al. Primary liver cancer: worldwide incidence and trends[J]. Gastroenterology,2004,127(5 Suppl 1):S5-16. doi: 10.1053/j.gastro.2004.09.011
|
| [33] |
Seeff LB,Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity[J]. Oncogene,2006,25(27): 3771-7. doi: 10.1038/sj.onc.1209560
|
| [33] |
Seeff LB, Hoofnagle JH. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity[J]. Oncogene, 2006, 25(27): 3771-7.
|
| [34] |
Chuang SC,La Vecchia C,Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection[J]. Cancer Lett,2009,286(1): 9-14. doi: 10.1016/j.canlet.2008.10.040
|
| [34] |
Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection[J]. Cancer Lett, 2009, 286(1): 9-14.
|
| [35] |
刘英, 赵桐, 徐英, 等. 河北省原发性肝癌易感因素的病例对照 研究[J]. 中国煤炭工业医学杂志, 2014, 17(12): 2009-12. [Liu Y, Zhao T, Xu Y, et al. A Case-Control Study on risk factors of Primary Hepati Caricnoma in Hebei[J]. Zhongguo Mei Tan Gong Ye Yi Xue Za Zhi, 2014, 17(12): 2009-12.]
|
| [35] |
刘英,赵桐,徐英,等. 河北省原发性肝癌易感因素的病例对照研究[J]. 中国煤炭工业医学杂志,2014,17(12): 2009-12. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMGY201412038.htm
Liu Y,Zhao T,Xu Y,et al. A Case-Control Study on risk factors of Primary Hepati Caricnoma in Hebei[J]. Zhongguo Mei Tan Gong Ye Yi Xue Za Zhi,2014,17(12): 2009-12. http://www.cnki.com.cn/Article/CJFDTOTAL-ZMGY201412038.htm
|
| [36] |
Zeng H, Zheng R, Guo Y, et al. Cancer survival in China, 2003-2005: a population-based study[J]. Int J Cancer, 2015, 136(8): 1921-30.
|
| [36] |
Zeng H,Zheng R,Guo Y,et al. Cancer survival in China,2003-2005: a population-based study[J]. Int J Cancer,2015,136(8): 1921-30. doi: 10.1002/ijc.29227
|
| [37] |
Wang JH, Changchien CS, Hu TH, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients[J]. Eur J Cancer, 2008, 44(7): 1000-6.
|
| [37] |
Wang JH,Changchien CS,Hu TH,et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-Survival analysis of 3892 patients[J]. Eur J Cancer,2008,44(7): 1000-6. doi: 10.1016/j.ejca.2008.02.018
|
| [38] |
Chen JG,Zhang SW. Liver cancer epidemic in China: past,present and future[J]. Semin Cancer Biol,2011,21(1): 59-69. doi: 10.1016/j.semcancer.2010.11.002
|
| [38] |
Chen JG, Zhang SW. Liver cancer epidemic in China: past, present and future[J]. Semin Cancer Biol, 2011, 21(1): 59-69.
|
| [39] |
Wang CH, Wey KC, Mo LR, et al. Current trends and recent advances in diagnosis, therapy, and prevention of hepatocellular carcinoma[J]. Asian Pac J Cancer Prev, 2015, 16(9): 3595-604.
|
| [39] |
Wang CH,Wey KC,Mo LR,et al. Current trends and recent advances in diagnosis,therapy,and prevention of hepatocellular carcinoma[J]. Asian Pac J Cancer Prev,2015,16(9): 3595-604. doi: 10.7314/APJCP.2015.16.9.3595
|
| [40] |
Miller ZA, Lee KS. Screening for hepatocellular carcinoma in high-risk populations[J]. Clin Imaging, 2016, 40(2): 311-4.
|
| [40] |
Miller ZA,Lee KS. Screening for hepatocellular carcinoma in high-risk populations[J]. Clin Imaging,2016,40(2): 311-4. doi: 10.1016/j.clinimag.2015.11.010
|
| [1] | KONG Yan, DONG Qian, LI Shuguang, XU Jinrui, ZHAO Xiaohan, DENG Wenzhao, SHEN Wenbin. Influence of Local Tumor Factors and Radiotherapy Dose on Prognosis of Clinical Stage T1-4N0M0 Esophageal Squamous Cell Carcinoma[J]. Cancer Research on Prevention and Treatment, 2025, 52(3): 225-232. DOI: 10.3971/j.issn.1000-8578.2025.24.0721 |
| [2] | XIA Lili, ZHU Xinyi, ZHANG Xiwei, LI Zhengjiang, LIU Shaoyan, LU Haizhen, AN Changming. Predictive Value of Depth of Invasion of Tongue Squamous Cell Carcinoma for Cervical Lymph Node Metastasis and Prognosis[J]. Cancer Research on Prevention and Treatment, 2022, 49(7): 675-681. DOI: 10.3971/j.issn.1000-8578.2022.21.1460 |
| [3] | LI Haiyan, ZHOU Xuan, CHEN Yunqing, JI Huihui, SHI Weiping, WANG Chengqin, XIANG Fenggang. Expression of KIF3A in Different Gastric Mucosal Lesions, Metastatic Lymph Nodes and Its Relationship with Metastasis and Prognosis of Gastric Adenocarcinoma[J]. Cancer Research on Prevention and Treatment, 2018, 45(12): 985-990. DOI: 10.3971/j.issn.1000-8578.2018.18.0627 |
| [4] | ZHAO Ruihua, JIANG Wenjing, ZHANG Weijie, CAO Xinguang. Metastasis?associated Lung Adenocarcinoma Transcript1(MALAT1) Expression in Middle Thoracic Esophageal Squamous Cell Cancer Tissues and Its Relationship with Prognosis[J]. Cancer Research on Prevention and Treatment, 2015, 42(12): 1227-1230. DOI: 10.3971/j.issn.1000-8578.2015.12.012 |
| [5] | LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007 |
| [6] | Zhen Chanjun, Zhou Zhiguo, Song Yuzhi, Qiao Xueying. Analysis of Therapeutic Effect and Prognosis of Radiotherapy for Patients with Esophageal Carcinoma with Supraclavicular Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2013, 40(01): 90-94. DOI: 10.3971/j.issn.1000-8578.2013.01.023 |
| [7] | LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Effects of KISS-1 Transfection on Tumor Growth of Nude Mice[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 136-140. DOI: 10.3971/j.issn.1000-8578.2010.02.004 |
| [8] | LI Na, LI Shan-shan, ZHANG Hong-yan, XUAN Xiao-yan, ZHENG Xian-zhao, WANG Feng, YAN Ai-hua. Construction of Eukaryotic Expression Plasmid pcDNA3.1-KISS-1 and Its Metastasis Inhibiting Effect to EC1 Cells[J]. Cancer Research on Prevention and Treatment, 2009, 36(04): 265-269. DOI: 10.3971/j.issn.1000-8578.2009.04.002 |
| [9] | GAO Zhao-hua. Analysis of Clinicopathologic Characteristics and Prognosis of Colorectal Cancer without Lymph Node Metastasis[J]. Cancer Research on Prevention and Treatment, 2008, 35(04): 272-274. DOI: 10.3971/j.issn.1000-8578.2697 |
| [10] | Huang jinqiu, . The significance of tumor angiogenesis in the invasion metastasis and judging the prognosis of gastric carcinoma[J]. Cancer Research on Prevention and Treatment, 1998, 25(6): 441-444. |
This work is licensed under a Creative Commons Attribution 3.0 License.
Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: